Warrants (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants And Rights Note Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Warrant Activity |
The following table summarizes information about the Company’s warrants at December 31, 2020 and September 30, 2020, respectively:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Information Assuming Warrants are Exercised and Exchanged for Common Shares |
The warrants may be exchanged for shares of common stock at a ratio of one share of Series B Preferred Stock into five common shares. The following table provides information assuming the warrants are exercised and exchanged for common shares:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Warrants Outstanding and Exercisable |
The exercise price for the Series B Convertible Preferred Stock warrants outstanding and exercisable at December 31, 2020 and September 30, 2020, are as follows:
|